United States Antihypertensive Drugs Market Report 2016

Global Info Research
120 Pages
Notes:
Sales, means the sales volume of Antihypertensive Drugs
Revenue, means the sales value of Antihypertensive Drugs

This report studies sales (consumption) of Antihypertensive Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Novartis AG
Pfizer
Sanofi S.A
Johnson & Johnson
Daiichi Sankyo
Merck & Co.
Ranbaxy Laboratories
Lupin
AstraZeneca
Dr. Reddy's Laboratories

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Angiotensin Converting Enzyme Inhibitors (ACE)
Diuretics
Beta Blockers
Calcium Channel Blockers
Vasodilators
Alpha blockers
Renin inhibitors
Split by applications, this report focuses on sales, market share and growth rate of Antihypertensive Drugs in each application, can be divided into
Diagnostic centers
Hospitals
Home health care

Table of Contents



United States Antihypertensive Drugs Market Report 2016

1 Antihypertensive Drugs Overview

1.1 Product Overview and Scope of Antihypertensive Drugs

1.2 Classification of Antihypertensive Drugs

1.2.1 Angiotensin Converting Enzyme Inhibitors (ACE)

1.2.2 Diuretics

1.2.3 Beta Blockers

1.2.4 Calcium Channel Blockers

1.2.5 Vasodilators

1.2.6 Alpha blockers

1.2.7 Renin inhibitors

1.3 Application of Antihypertensive Drugs

1.3.1 Diagnostic centers

1.3.2 Hospitals

1.3.3 Home health care

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antihypertensive Drugs (2011-2021)

1.4.1 United States Antihypertensive Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States Antihypertensive Drugs Revenue and Growth Rate (2011-2021)



2 United States Antihypertensive Drugs Competition by Manufacturers

2.1 United States Antihypertensive Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Antihypertensive Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Antihypertensive Drugs Average Price by Manufactures (2015 and 2016)

2.4 Antihypertensive Drugs Market Competitive Situation and Trends

2.4.1 Antihypertensive Drugs Market Concentration Rate

2.4.2 Antihypertensive Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion



3 United States Antihypertensive Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Antihypertensive Drugs Sales and Market Share by Type (2011-2016)

3.2 United States Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States Antihypertensive Drugs Price by Type (2011-2016)

3.4 United States Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)



4 United States Antihypertensive Drugs Sales (Volume) by Application (2011-2016)

4.1 United States Antihypertensive Drugs Sales and Market Share by Application (2011-2016)

4.2 United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities



5 United States Antihypertensive Drugs Manufacturers Profiles/Analysis

5.1 Novartis AG

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Antihypertensive Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Pfizer

5.2.2 Antihypertensive Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Sanofi S.A

5.3.2 Antihypertensive Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Johnson & Johnson

5.4.2 Antihypertensive Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Daiichi Sankyo

5.5.2 Antihypertensive Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Merck & Co.

5.6.2 Antihypertensive Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Ranbaxy Laboratories

5.7.2 Antihypertensive Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Lupin

5.8.2 Antihypertensive Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 AstraZeneca

5.9.2 Antihypertensive Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Dr. Reddy's Laboratories

5.10.2 Antihypertensive Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview



6 Antihypertensive Drugs Manufacturing Cost Analysis

6.1 Antihypertensive Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Antihypertensive Drugs



7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Antihypertensive Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015

7.4 Downstream Buyers



8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List



9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change



10 United States Antihypertensive Drugs Market Forecast (2016-2021)

10.1 United States Antihypertensive Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States Antihypertensive Drugs Sales Forecast by Type (2016-2021)

10.3 United States Antihypertensive Drugs Sales Forecast by Application (2016-2021)

10.4 Antihypertensive Drugs Price Forecast (2016-2021)



11 Research Findings and Conclusion



12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer




List of Tables and Figures



Figure Picture of Antihypertensive Drugs

Table Classification of Antihypertensive Drugs

Figure United States Sales Market Share of Antihypertensive Drugs by Type in 2015

Figure Angiotensin Converting Enzyme Inhibitors (ACE) Picture

Figure Diuretics Picture

Figure Beta Blockers Picture

Figure Calcium Channel Blockers Picture

Figure Vasodilators Picture

Figure Alpha blockers Picture

Figure Renin inhibitors Picture

Table Application of Antihypertensive Drugs

Figure United States Sales Market Share of Antihypertensive Drugs by Application in 2015

Figure Diagnostic centers Examples

Figure Hospitals Examples

Figure Home health care Examples

Figure United States Antihypertensive Drugs Sales and Growth Rate (2011-2021)

Figure United States Antihypertensive Drugs Revenue and Growth Rate (2011-2021)

Table United States Antihypertensive Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Antihypertensive Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Antihypertensive Drugs Sales Share by Manufacturers

Figure 2016 Antihypertensive Drugs Sales Share by Manufacturers

Table United States Antihypertensive Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Antihypertensive Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Antihypertensive Drugs Revenue Share by Manufacturers

Table 2016 United States Antihypertensive Drugs Revenue Share by Manufacturers

Table United States Market Antihypertensive Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Antihypertensive Drugs Average Price of Key Manufacturers in 2015

Figure Antihypertensive Drugs Market Share of Top 3 Manufacturers

Figure Antihypertensive Drugs Market Share of Top 5 Manufacturers

Table United States Antihypertensive Drugs Sales by Type (2011-2016)

Table United States Antihypertensive Drugs Sales Share by Type (2011-2016)

Figure United States Antihypertensive Drugs Sales Market Share by Type in 2015

Table United States Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)

Table United States Antihypertensive Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Antihypertensive Drugs by Type (2011-2016)

Table United States Antihypertensive Drugs Price by Type (2011-2016)

Figure United States Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)

Table United States Antihypertensive Drugs Sales by Application (2011-2016)

Table United States Antihypertensive Drugs Sales Market Share by Application (2011-2016)

Figure United States Antihypertensive Drugs Sales Market Share by Application in 2015

Table United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)

Figure United States Antihypertensive Drugs Sales Growth Rate by Application (2011-2016)

Table Novartis AG Basic Information List

Table Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG Antihypertensive Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Antihypertensive Drugs Sales Market Share (2011-2016)

Table Sanofi S.A Basic Information List

Table Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A Antihypertensive Drugs Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Antihypertensive Drugs Sales Market Share (2011-2016)

Table Daiichi Sankyo Basic Information List

Table Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Antihypertensive Drugs Sales Market Share (2011-2016)

Table Merck & Co. Basic Information List

Table Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Antihypertensive Drugs Sales Market Share (2011-2016)

Table Ranbaxy Laboratories Basic Information List

Table Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ranbaxy Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)

Table Lupin Basic Information List

Table Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lupin Antihypertensive Drugs Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Antihypertensive Drugs Sales Market Share (2011-2016)

Table Dr. Reddy's Laboratories Basic Information List

Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antihypertensive Drugs

Figure Manufacturing Process Analysis of Antihypertensive Drugs

Figure Antihypertensive Drugs Industrial Chain Analysis

Table Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015

Table Major Buyers of Antihypertensive Drugs

Table Distributors/Traders List

Figure United States Antihypertensive Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States Antihypertensive Drugs Production Forecast by Type (2016-2021)

Table United States Antihypertensive Drugs Consumption Forecast by Application (2016-2021)



captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Report's License Type

$3800
$7600

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.